Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-25 Purchase |
2023-10-27 4:15 pm |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director 10% Owner |
7,933,601 | $0.7568 | $6,004,149 | 14,992,741 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 4:33 pm |
N/A 2035-02-28 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE President and CEO |
140,103 | $0 | 140,103 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:33 pm |
N/A 2035-02-28 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
21,693 | $0 | 21,693 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:32 pm |
N/A 2035-02-28 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
47,271 | $0 | 47,271 (Direct) |
View |
| 2024-10-08 Option Award |
2024-10-10 4:16 pm |
N/A 2034-10-08 |
Aligos Therapeutics Inc. | ALGS | Achneck Hardean Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2024-09-04 Option Award |
2024-09-06 4:23 pm |
N/A 2034-09-04 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
10,880 | $0 | 10,880 (Direct) |
View |
| 2024-09-04 Option Award |
2024-09-06 4:23 pm |
N/A 2034-09-04 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
33,920 | $0 | 33,920 (Direct) |
View |
| 2024-09-04 Option Award |
2024-09-06 4:22 pm |
N/A 2034-09-04 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
10,880 | $0 | 10,880 (Direct) |
View |
| 2024-08-07 Option Award |
2024-08-09 4:09 pm |
N/A 2034-08-07 |
Aligos Therapeutics Inc. | ALGS | Chavez Margarita Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-08-07 Option Award |
2024-08-09 4:08 pm |
N/A 2034-08-07 |
Aligos Therapeutics Inc. | ALGS | Preston Heather Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-06-28 4:08 pm |
N/A 2034-06-27 |
Aligos Therapeutics Inc. | ALGS | Hirth Peter Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-06-28 4:08 pm |
N/A 2034-06-27 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-06-28 4:07 pm |
N/A 2034-06-27 |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-06-28 4:07 pm |
N/A 2034-06-27 |
Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:44 pm |
N/A 2034-03-01 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
72,000 | $0 | 72,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:42 pm |
N/A 2034-03-01 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
308,940 | $0 | 308,940 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:42 pm |
N/A 2034-03-01 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
72,000 | $0 | 72,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:41 pm |
N/A 2024-03-01 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
965,435 | $0 | 965,435 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:35 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Hirth Peter Director |
4,411 | $0 | 4,411 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:34 pm |
N/A 2031-04-26 |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
8,823 | $0 | 8,823 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:33 pm |
N/A 2030-12-01 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
157,324 | $0 | 157,324 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:32 pm |
N/A 2030-12-01 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
145,581 | $0 | 145,581 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:32 pm |
N/A 2030-12-01 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
421,100 | $0 | 421,100 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:31 pm |
N/A 2030-12-01 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
152,570 | $0 | 152,570 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:30 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director |
4,411 | $0 | 4,411 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:29 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
4,411 | $0 | 4,411 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:29 pm |
N/A 2031-11-16 |
Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director |
8,823 | $0 | 8,823 (Direct) |
View |
Ownership |
2023-11-07 5:14 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner |
0 | $0 | 14,992,741 (Indirect) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:14 pm |
2023-10-25 2030-10-25 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
305,138 | $0.125 | 2,425,771 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:14 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
610,277 | $0.7568 | 2,425,771 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:13 pm |
2023-10-25 2030-10-25 |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
91,541 | $0.125 | 274,624 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:13 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
183,083 | $0.7568 | 274,624 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:08 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:07 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:07 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:06 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:05 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 9:06 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 7:23 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director |
20,000 | $0 | 20,000 (Direct) |
View |